483
Shore Institute For Reproductive Medicine, P.C.Shore Institute For Reproductive Medicine, P.C. – FDA 483, Mar 5, 2008
Record Details
The FDA inspected Shore Institute for Reproductive Medicine, P.C. in Lakewood, NJ, an in vitro fertilization establishment. The inspection revealed significant deficiencies in donor screening and testing for communicable diseases, as well as inadequate documentation for donor eligibility determinations and procedure approvals. These issues indicate a serious lack of control over the safety and eligibility of oocyte donors and the HCT/Ps derived from them.
- Inspection date
- March 5, 2008
- Product type
- biologics
View Company Profile
ID · 67bd7cf3-83fe-474d-aab7-f6a263d6d97e
Other documents for Shore Institute For Reproductive Medicine, P.C.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.